Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-015634
Filing Date
2013-03-08
Accepted
2013-03-08 14:52:28
Documents
1
Period of Report
2013-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd373555.html 4  
1 FORM 4 rrd373555.xml 4 10367
  Complete submission text file 0001181431-13-015634.txt   11700
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
MILLER DANIEL H (Reporting) CIK: 0000902448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35189 | Film No.: 13676895

Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals